4D pharma plc filed its 20-F on Mar 31, 2022 for the period ending Dec 31, 2021. In this report its auditor, McGladrey LLP - RSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+8.64% | 105B | |
-0.90% | 104B | |
+5.44% | 22.94B | |
-12.25% | 22.34B | |
-6.31% | 19.25B | |
-37.08% | 17.08B | |
-8.69% | 16.96B | |
+7.59% | 14.16B | |
+38.96% | 12.63B |